Myeloid cells as target of fingolimod action in multiple sclerosis

OBJECTIVE: To track the effects of fingolimod, an approved drug for multiple sclerosis (MS), on the activation of myeloid cells from the periphery to the CNS. METHODS: In vitro and ex vivo immunologic studies coupled with flow cytometry were performed to evaluate the action of fingolimod on lipopoly...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Dario, Marco, Colombo, Emanuela, Govi, Chiara, De Feo, Donatella, Messina, Maria José, Romeo, Marzia, Sangalli, Francesca, Moiola, Lucia, Rodegher, Mariaemma, Martino, Gianvito, Martinelli, Vittorio, Comi, Giancarlo, Farina, Cinthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635549/
https://www.ncbi.nlm.nih.gov/pubmed/26587553
http://dx.doi.org/10.1212/NXI.0000000000000157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635549/
https://www.ncbi.nlm.nih.gov/pubmed/26587553
http://dx.doi.org/10.1212/NXI.0000000000000157

Ejemplares similares